|
Volumn 67, Issue 4, 2004, Pages 54-56
|
Antitumor activity of the new gestagen 17α-acetoxy-3β- butanoyloxy-6-methyl-pregna-4,6-dien-20-one
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
17ALPHA ACETOXY 3BETA BUTANOYLOXY 6 METHYLPREGNA 4,6 DIEN 20 ONE;
GESTAGEN;
MEDROXYPROGESTERONE ACETATE;
PROGESTERONE;
UNCLASSIFIED DRUG;
17ALPHA ACETOXY 3BETA BUTANOYLOXY 6 METHYL PREGNA 4,6 DIEN 20 ONE;
17ALPHA-ACETOXY-3BETA-BUTANOYLOXY-6-METHYL-PREGNA-4,6-DIEN-20-ONE;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
HYDROXYPROGESTERONE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CARCINOGENESIS;
CELL VIABILITY;
CONCENTRATION RESPONSE;
DRUG EFFICACY;
HELA CELL;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
INCUBATION TIME;
MOUSE;
NONHUMAN;
TUMOR GROWTH;
UTERINE CERVIX CARCINOMA;
ANIMAL;
BREAST TUMOR;
CARCINOMA;
CBA MOUSE;
CELL PROLIFERATION;
DRUG EFFECT;
FEMALE;
TUMOR CELL LINE;
UTERINE CERVIX TUMOR;
17-ALPHA-HYDROXYPROGESTERONE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CARCINOMA;
CELL LINE, TUMOR;
CELL PROLIFERATION;
FEMALE;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
MICE;
MICE, INBRED CBA;
PROGESTINS;
UTERINE CERVICAL NEOPLASMS;
|
EID: 4644310201
PISSN: 08692092
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (8)
|